170 related articles for article (PubMed ID: 36720356)
1. Modulation of p38 MAPK and Nrf2/HO-1/NLRP3 inflammasome signaling and pyroptosis outline the anti-neuroinflammatory and remyelinating characters of Clemastine in EAE rat model.
Motawi TK; El-Maraghy SA; Kamel AS; Said SE; Kortam MA
Biochem Pharmacol; 2023 Mar; 209():115435. PubMed ID: 36720356
[TBL] [Abstract][Full Text] [Related]
2. Hesperetin ameliorates spinal cord injury by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling.
Liu Z; Tu K; Zou P; Liao C; Ding R; Huang Z; Huang Z; Yao X; Chen J; Zhang Z
Int Immunopharmacol; 2023 May; 118():110103. PubMed ID: 37001385
[TBL] [Abstract][Full Text] [Related]
3. The preferential effect of Clemastine on F3/Contactin-1/Notch-1 compared to Jagged-1/Notch-1 justifies its remyelinating effect in an experimental model of multiple sclerosis in rats.
Ibrahim SM; Kamel AS; Ahmed KA; Mohammed RA; Essam RM
Int Immunopharmacol; 2024 Feb; 128():111481. PubMed ID: 38232534
[TBL] [Abstract][Full Text] [Related]
4. Pinocembrin suppresses oxidized low-density lipoprotein-triggered NLRP3 inflammasome/GSDMD-mediated endothelial cell pyroptosis through an Nrf2-dependent signaling pathway.
Wang T; Tian H; Pan T; Yao S; Yu H; Wu Y; Wang S
Sci Rep; 2022 Aug; 12(1):13885. PubMed ID: 35974041
[TBL] [Abstract][Full Text] [Related]
5. IRAK-M suppresses the activation of microglial NLRP3 inflammasome and GSDMD-mediated pyroptosis through inhibiting IRAK1 phosphorylation during experimental autoimmune encephalomyelitis.
Wang Y; Pei S; Liu Z; Ding Y; Qian T; Wen H; Hsu SW; Zhou Z; Zhang J; Wang H
Cell Death Dis; 2023 Feb; 14(2):103. PubMed ID: 36765034
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain.
Khan N; Kuo A; Brockman DA; Cooper MA; Smith MT
Inflammopharmacology; 2018 Feb; 26(1):77-86. PubMed ID: 28965161
[TBL] [Abstract][Full Text] [Related]
7. Acrylamide Induces Neurotoxicity in SH-SY5Y Cells via NLRP3-mediated Pyroptosis.
Zhao M; Zhang B; Deng L; Zhao L
Mol Neurobiol; 2023 Feb; 60(2):596-609. PubMed ID: 36324051
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome.
Wang X; Li B; Liu L; Zhang L; Ma T; Guo L
Int Immunopharmacol; 2021 Jan; 90():107092. PubMed ID: 33290962
[TBL] [Abstract][Full Text] [Related]
9. Ellagic acid ameliorates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis: Involvement of NLRP3 and pyroptosis.
Kiasalari Z; Afshin-Majd S; Baluchnejadmojarad T; Azadi-Ahmadabadi E; Esmaeil-Jamaat E; Fahanik-Babaei J; Fakour M; Fereidouni F; Ghasemi-Tarie R; Jalalzade-Ogvar S; Khodashenas V; Sanaierad A; Zahedi E; Roghani M
J Chem Neuroanat; 2021 Jan; 111():101891. PubMed ID: 33217488
[TBL] [Abstract][Full Text] [Related]
10. Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).
Barclay W; Shinohara ML
Brain Pathol; 2017 Mar; 27(2):213-219. PubMed ID: 27997058
[TBL] [Abstract][Full Text] [Related]
11. Sinomenine Alleviates Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis through Inhibiting NLRP3 Inflammasome.
Kiasalari Z; Afshin-Majd S; Baluchnejadmojarad T; Azadi-Ahmadabadi E; Fakour M; Ghasemi-Tarie R; Jalalzade-Ogvar S; Khodashenas V; Tashakori-Miyanroudi M; Roghani M
J Mol Neurosci; 2021 Feb; 71(2):215-224. PubMed ID: 32812186
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype.
Hou B; Zhang Y; Liang P; He Y; Peng B; Liu W; Han S; Yin J; He X
Cell Death Dis; 2020 May; 11(5):377. PubMed ID: 32415059
[TBL] [Abstract][Full Text] [Related]
13. Minocycline alleviates NLRP3 inflammasome-dependent pyroptosis in monosodium glutamate-induced depressive rats.
Yang F; Zhu W; Cai X; Zhang W; Yu Z; Li X; Zhang J; Cai M; Xiang J; Cai D
Biochem Biophys Res Commun; 2020 Jun; 526(3):553-559. PubMed ID: 32245616
[TBL] [Abstract][Full Text] [Related]
14. Potential role of BAY11-7082, a NF-κB blocker inhibiting experimental autoimmune encephalomyelitis in C57BL/6J mice via declining NLRP3 inflammasomes.
Lang Y; Chu F; Liu L; Zheng C; Li C; Shen D; Liu S; Zhang W; Cui L; Zhu J
Clin Exp Immunol; 2022 May; 207(3):378-386. PubMed ID: 35553640
[TBL] [Abstract][Full Text] [Related]
15. The zebrafish NLRP3 inflammasome has functional roles in ASC-dependent interleukin-1β maturation and gasdermin E-mediated pyroptosis.
Li JY; Wang YY; Shao T; Fan DD; Lin AF; Xiang LX; Shao JZ
J Biol Chem; 2020 Jan; 295(4):1120-1141. PubMed ID: 31852739
[TBL] [Abstract][Full Text] [Related]
16. Bixin Attenuates Experimental Autoimmune Encephalomyelitis by Suppressing TXNIP/NLRP3 Inflammasome Activity and Activating NRF2 Signaling.
Yu Y; Wu DM; Li J; Deng SH; Liu T; Zhang T; He M; Zhao YY; Xu Y
Front Immunol; 2020; 11():593368. PubMed ID: 33362775
[TBL] [Abstract][Full Text] [Related]
17. Eldecalcitol Inhibits LPS-Induced NLRP3 Inflammasome-Dependent Pyroptosis in Human Gingival Fibroblasts by Activating the Nrf2/HO-1 Signaling Pathway.
Huang C; Zhang C; Yang P; Chao R; Yue Z; Li C; Guo J; Li M
Drug Des Devel Ther; 2020; 14():4901-4913. PubMed ID: 33223823
[TBL] [Abstract][Full Text] [Related]
18. AZD8055 ameliorates experimental autoimmune encephalomyelitis via the mTOR/ROS/NLRP3 pathway.
He M; Wu DM; Zhao YY; Yu Y; Deng SH; Liu T; Zhang T; Li J; Wang F; Xu Y
Biochem Biophys Res Commun; 2021 Oct; 573():27-34. PubMed ID: 34384953
[TBL] [Abstract][Full Text] [Related]
19. Melatonin alleviates lipopolysaccharide (LPS) / adenosine triphosphate (ATP)-induced pyroptosis in rat alveolar Type II cells (RLE-6TN) through nuclear factor erythroid 2-related factor 2 (Nrf2)-driven reactive oxygen species (ROS) downregulation.
Zhou T; Li Z; Chen H
Bioengineered; 2022 Jan; 13(1):1880-1892. PubMed ID: 35109747
[TBL] [Abstract][Full Text] [Related]
20. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
Lv C; Cheng T; Zhang B; Sun K; Lu K
Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748
[No Abstract] [Full Text] [Related]
[Next] [New Search]
